{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:14:18Z","timestamp":1784121258502,"version":"3.55.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"932","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that is endemic in certain regions of the world, and may account for significant morbidity and mortality among hospitalised patients.<\/jats:p>\n               <jats:p>Sixty six HTLV-1 seropositive patients admitted to hospital with HTLV-1 associated diseases from 1995\u201399 were studied. HTLV-1 screening was done with ELISA and confirmed on western blot testing. There were 32 females (48.5%) and 34 males (51.5%). The mean age was 56 years and the age range was 9\u201389 years.<\/jats:p>\n               <jats:p>The main associated diseases were tropical spastic paraparesis or HTLV-1 associated myelopathy in 18.2% of cases, acute form of adult T-cell leukaemia\/lymphoma 7.6%, lymphomas 15.2%, and ectoparasites\/endoparasites in 40.9%. HTLV-1 is associated with diseases in Dominica and association with severe forms of strongyloidiasis and scabies is particularly noted.<\/jats:p>","DOI":"10.1136\/pmj.79.932.341","type":"journal-article","created":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T20:30:33Z","timestamp":1057091433000},"page":"341-344","source":"Crossref","is-referenced-by-count":13,"title":["Hospital admissions for human T-cell lymphotropic virus type-1 (HTLV-1) associated diseases in Dominica"],"prefix":"10.1093","volume":"79","author":[{"given":"O","family":"Adedayo","sequence":"first","affiliation":[{"name":"Department of Medicine, Princess Margaret Hospital and Ross University School of Medicine , Dominica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Grell","sequence":"additional","affiliation":[{"name":"Department of Medicine, Princess Margaret Hospital and Ross University School of Medicine , Dominica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bellot","sequence":"additional","affiliation":[{"name":"Department of Pathology, Princess Margaret Hospital and Ross University School of Medicine , Dominica"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2003,6,1]]},"reference":[{"key":"2023042410201363400_R1","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023042410201363400_R2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/aid.1993.9.381","article-title":"An HTLV-1 vaccine: why, how, for whom?","volume":"9","author":"de The","year":"1993","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2023042410201363400_R3","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/00042560-199600001-00002","article-title":"Findings from the Miyazaki cohort study","volume":"13","author":"Mueller","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"2023042410201363400_R4","first-page":"4","article-title":"Heterosexual transmission of HTLV-1; epidemiological aspects","volume":"45","author":"Figueroa","year":"1996","journal-title":"W I Med J"},{"key":"2023042410201363400_R5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematological features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"2023042410201363400_R6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis","volume":"ii","author":"Gessain","year":"1985","journal-title":"Lancet"},{"key":"2023042410201363400_R7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-1 associated myelopathy, a new clinical entity","volume":"i","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"2023042410201363400_R8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/bjo.78.2.149","article-title":"Human T-lymphotropic virus type 1 uveitis","volume":"78","author":"Mochizuki","year":"1994","journal-title":"Br J Ophthalmol"},{"key":"2023042410201363400_R9","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(90)92896-P","article-title":"Infective dermatitis of Jamaican children: a marker for HTLV-1 infection","volume":"336","author":"la Grenade","year":"1990","journal-title":"Lancet"},{"key":"2023042410201363400_R10","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0140-6736(89)91793-5","article-title":"HTLV-1 and polymyositis in Jamaica","volume":"ii","author":"Morgan O st","year":"1989","journal-title":"Lancet"},{"key":"2023042410201363400_R11","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(94)90630-0","article-title":"Prevalence of serum and salivary antibodies to HTLV-1 in Sjogren\u2019s syndrome","volume":"344","author":"Terada","year":"1994","journal-title":"Lancet"},{"key":"2023042410201363400_R12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0035-9203(94)90403-0","article-title":"Seroprevalence of HTLV-1 in chronic disease patients in Jamaica","volume":"88","author":"Barton","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2023042410201363400_R13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/art.1780340612","article-title":"Arthritis in patients infected with human T-lymphotropic virus type-1. Clinical and immuno-pathological features","volume":"34","author":"Sato","year":"1991","journal-title":"Arthritis Rheum"},{"key":"2023042410201363400_R14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/clinids\/23.1.138","article-title":"Infections complications of human T-cell leukemia\/lymphoma virus type 1 infection","volume":"23","author":"Marsh","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2023042410201363400_R15","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/jnci\/87.13.1009","article-title":"Effect of human T-lymphotropic virus type-1 infection on non-Hodgkin\u2019s lymphoma incidence","volume":"87","author":"Cleghorn","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"2023042410201363400_R16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00042560-199802010-00011","article-title":"Incidence of HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Jamaica and Trinidad","volume":"17","author":"Maloney","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retroviral"},{"key":"2023042410201363400_R17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev.immunol.15.1.15","article-title":"Human T-cell leukemia virus type 1 (HTLV-1) and human diseases","volume":"15","author":"Uchiyama","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"2023042410201363400_R18","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/00042560-199600001-00005","article-title":"Adult T-cell leukemia\/lymphoma in Jamaica 1986\u20131995","volume":"13","author":"Hanchard","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"2023042410201363400_R19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/10428199209053580","article-title":"Risk of adult T-cell leukemia developing in individuals with HTLV-1 infection","volume":"6","author":"Kamihira","year":"1992","journal-title":"Leuk Lymphoma"},{"key":"2023042410201363400_R20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.7326\/0003-4819-118-6-199303150-00009","article-title":"Guidelines for counseling of persons infected with human T-lymphotropic virus type (HTLV-1) and type 11 (HTLV-1)","volume":"118","author":"Centers for Disease Control and Prevention and the USHS Working Group","year":"1993","journal-title":"Ann Intern Med"},{"key":"2023042410201363400_R21","first-page":"399","article-title":"HTLV-1 and co-infections","volume":"51","author":"Brosset","year":"1991","journal-title":"Med Trop"},{"key":"2023042410201363400_R22","first-page":"2127","article-title":"Malignant strongyloidiasis and the HTLV-1 virus","volume":"40","author":"Neisson-Vernant","year":"1990","journal-title":"Rev Pract"},{"key":"2023042410201363400_R23","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4269\/ajtmh.2001.65.650","article-title":"Fatal strongyloidiasis associated with human T-cell lymphotropic virus type-1 infection","volume":"65","author":"Adedayo","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"2023042410201363400_R24","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0140-6736(93)91186-P","article-title":"HTLV-1 and scabies an Australian aborigines (letter)","volume":"341","author":"Mollison","year":"1993","journal-title":"Lancet"},{"key":"2023042410201363400_R25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0190-9622(97)70353-0","article-title":"Scabies in HTLV-1 seropositive patients (letter)","volume":"36","author":"Del Guidice","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"2023042410201363400_R26","first-page":"411","article-title":"Gastrointestinal parasitic infection in healthy Jamaican carriers of HTLV-1","volume":"94","author":"Robinson","year":"1991","journal-title":"J Trop Med Hyg"},{"key":"2023042410201363400_R27","first-page":"39","article-title":"The clinical significance of HTLV-1 and HTLV-11 infection in the AIDS epidemic","author":"Pierik","year":"1991","journal-title":"AIDS Clin Rev"},{"key":"2023042410201363400_R28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2249.1990.tb03319.x","article-title":"Decreased serum levels of IgE and IgE binding factors in individuals infected with HTLV-1","volume":"81","author":"Matsumoto","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"2023042410201363400_R29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0002-9343(92)90113-P","article-title":"Strongyloides stercoralis infection in a carrier of HTLV-1 virus with evidence of selective immunosuppression","volume":"92","author":"Newton","year":"1992","journal-title":"Am J Med"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/79\/932\/341\/50038828\/postgradmedj-79-341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/79\/932\/341\/50038828\/postgradmedj-79-341.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T10:54:08Z","timestamp":1682333648000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/79\/932\/341\/7045758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,1]]},"references-count":29,"journal-issue":{"issue":"932","published-online":{"date-parts":[[2003,6,1]]},"published-print":{"date-parts":[[2003,6,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pmj.79.932.341","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2003,6]]},"published":{"date-parts":[[2003,6,1]]}}}